11 results
8-K
SPRY
ARS Pharmaceuticals Inc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
her tenure at AnGes Inc., a biopharmaceutical company, and also served as a clinical scientist at Roche, a research healthcare company, where she … to his tenure at Azur Pharma, he served as Vice President of Commercial Operations at Guilford Pharmaceuticals Inc., a biopharmaceutical company, Vice
DEFA14A
SPRY
ARS Pharmaceuticals Inc
21 Jul 22
Additional proxy soliciting materials
5:05pm
to all employees based on level of position and tenure with Silverback, which include severance pay, paid COBRA, and outplacement services. The severance
8-K
EX-99.4
SPRY
ARS Pharmaceuticals Inc
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
and associated space.
We will be offering severance packages to all employees based on level of position and tenure with Silverback, which include severance
8-K
EX-3.2
q4yp5yl 1imvrv75mwh
8 Dec 20
Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
5:25pm
S-1
EX-3.3
zcfhg 4xfs0okt
10 Nov 20
IPO registration
4:46pm
S-1
EX-3.4
e3y53ey1al 1a0
10 Nov 20
IPO registration
4:46pm
S-1
EX-10.9
p5ea4 r6g
10 Nov 20
IPO registration
4:46pm
DRS
EX-10.9
kkbmhg
2 Oct 20
Draft registration statement
12:00am
DRS
EX-3.3
6lst0 f8e
2 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next